Dr. Ananya Mandal

Dr. Ananya Mandal

Feature Writer

MD

Clinical Pharmacologist

Dr. Ananya Mandal is a medical doctor, having achieved her MBBS degree in 2002 from Calcutta National Medical College & Hospital, followed by an MD in Clinical Pharmacology and Therapeutics from The Institute of Post graduate Medical Education and Research, West Bengal.

See more

At present she works as an Associate Professor at a Government Medical College in West Bengal, teaching Pharmacology to second year MBBS students and also post-graduate students pursuing an MD.

Dr. Mandal has been writing research articles and synopses of complex studies for many years, making things easier and simpler for students and other academic professionals to understand.

Dr. Mandal is passionate about bringing health science to people from non-science backgrounds and has been writing health and drug-related articles for the general public for over a decade.

She is a consultant for most of her colleagues and friends, not only when it comes to health and wellness issues but also about medications, and possible drug-drug and drug-food interactions. Dr. Mandal is a passionate advocate of good newborn care, breastfeeding, child rearing practices and hopes to reach out to new mothers in remote locations with little access to good healthcare, dispelling myths and superstitions.

Dr. Mandal also works as a medical writer for the pharmaceutical industry, preparing scientific and authentic drug promotional literature. She prepares study material for practitioners for CMEs, focussing on rational drug prescribing and therapeutics. In this capacity, she has worked with some of the world’s leading pharmaceutical establishments, writing on newly launched drugs, vaccines and drug combinations.

Dr. Mandal is the co-ordinator for the Adverse Drug Reaction Monitoring Centre (AMC) for her college. She and her team routinely visit the different wards and out-patient departments, gathering information on side effects and therapeutic misadventures and reporting them to the central department of Pharmacovigilance under the National Pharmacovigilance Programme (PvPI).

From the centre in New Delhi, these reports are directly sent to Uppsala, Sweden, to their databases. She feels passionately about constant vigilance regarding new and serious adverse events related to medication use.

She has experience with drug prescribing challenges in children and in the elderly population and has several research activities and publications related to rational drug prescribing even in the remotest of health centres of her region.

Another area of Ananya’s work includes the advancement of Medical education technology among existing medical teachers. She is the Joint co-ordinator of the Medical Education Unit (MEU) of her college and routinely hosts workshops and speaks at training sessions, panel discussions and symposiums for her colleagues and fellow teachers.

At these events, delegates discuss the implementation of new and more advanced methods of effective medical education. She has published numerousresearch papers and has several ongoing research activities related to medical education and its challenges in today’s society.

One of her key areas of interest is the development of effective ethical and communication skills among medical students. She believes in effective ethical practice and communication with the patients to be the foundation for good clinical practice. Here, she focuses on methods of communication of various health and drug related issues to the general public by fresh medical graduates to minimize doctor-patient conflicts and to improve therapeutic outcomes and satisfaction.

Dr. Mandal's continued attachment to the online platforms where she writes, is an attempt to make correct medical information accessible to the general public. She believes in patient education and awareness and preventive medicine along with rational therapeutics and hopes to fulfill her role as an educator and teacher as well as a Clinical Pharmacologist.

See less

Articles from Ananya

Heart attack and stroke prevention efforts need a boost says CDC

Heart attack and stroke prevention efforts need a boost says CDC

Breast cancer cases among men who were at ground zero on 9/11

Breast cancer cases among men who were at ground zero on 9/11

The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers. 

This new data emerges from a client list of a law firm that is specially looking into health cases of those in and around the region on 9/11. There could be many more men who are outside of this data base say experts. Two of the men – Jeff Flynn (65 years old) and John Mormando (51 years old) who were near the zone were initially diagnosed with the cancer and are being treated for it. Both men say that there is no history of breast cancers in their family and they were exposed to toxins on the day.

Flynn was an account manager for a data-storage company Dell EMC and was assigned to Goldman Sachs on Maiden Lane on the fateful day. He was around the region for months after the attack helping Goldman and other financial services firms to set up again.

After a decade, in 2011, he first noticed an abnormality in one of his nipples and was then diagnosed with stage 3 breast cancer for which he underwent extensive operations. Soon the cancer returned as a stage 4 cancer. He was awarded compensation from the September 11th Victim Compensation Fund that helped him pay for his treatment. Mormando was a commodities broker working at the Mercantile Exchange until 2007. He is a triathlete now. Last year he noticed a lump on his chest and was diagnosed with the breast cancer.

Leon Silverstein (89 years old), an Army veteran, was diagnosed with breast cancer and had to be operated upon. As a result of the cancer both his breasts had to be removed in a double mastectomy. He used to live near Battery Park near the Ground Zero for 30 years.

Experts believe that apart from those killed during the attacks more people are emerging with long term after effects of the attack. There are over ten thousand individuals who were members of the first responders’ teams for rescue operations or were near the region when the attack took place.

These people have been diagnosed with various forms of cancers due to exposure to the toxins. Over 2000 individuals have ailments that can be attributed to the toxins on that day. The Chief of the fire Department of New York, for example, who was leading the first responder efforts died this June from cancer.

Japan acknowledges death due to radiation exposure at Fukushima nuclear power plant

Japan acknowledges death due to radiation exposure at Fukushima nuclear power plant

Superbugs emerging from skin bacteria on the increase

Superbugs emerging from skin bacteria on the increase

Airport security trays carry more microbes than toilet seats

Airport security trays carry more microbes than toilet seats

Gene therapy for rare genetic blindness wins prestigious Champalimaud Vision award

Gene therapy for rare genetic blindness wins prestigious Champalimaud Vision award

Over one in four adults worldwide is inactive finds study

Over one in four adults worldwide is inactive finds study

Clinical recommendations regarding mild traumatic brain injury (mTBI) released

Clinical recommendations regarding mild traumatic brain injury (mTBI) released

Muscle dystrophy treatment in dogs with Crispr gene editing

Muscle dystrophy treatment in dogs with Crispr gene editing

Mediterranean diet could be better than ‘Viagra’ for erectile dysfunction

Mediterranean diet could be better than ‘Viagra’ for erectile dysfunction

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.